| Literature DB >> 34150884 |
Luis Anel-Lopez1,2, Marta F Riesco1,3, Rafael Montes-Garrido1,2, Marta Neila-Montero1,2, Juan C Boixo1,2, César Chamorro1,2, Cristina Ortega-Ferrusola4, Ana Carvajal5, Jose R Altonaga2, Paulino de Paz1,3, Mercedes Alvarez1,2, Luis Anel1,2.
Abstract
It is crucial to perform a deep study about the most extensively used antibiotics in sperm extenders. Most of the protocols and concentrations used in ram are direct extrapolations from other species. It is important to establish species-specific antibiotic treatments to optimize their use and if it is possible to reduce the quantity. Previews studies have assessed some aspects of sperm quality in vitro, but this study aimed to go further and assess the effect of three different antibiotic treatments, which are the most extensively used, not only in sperm quality or assessing the inhibitory effect on bacterial growth but also assessing these important parameters of productivity such as fertility, prolificacy, fecundity, and sex-ratio during a freeze-thaw process. Gentamicyn (G) treatment showed the worst results, not only concerning sperm quality but also in the reproductive trials exhibiting a toxical effect at the experiment concentration, and being the most powerful inhibiting bacterial growth. For its part, Lincomicyn-spectinomycin (LS) showed similar results inhibiting bacterial growth but it did not show a detrimental effect either in sperm quality or in reproductive parameters. Penicillin-streptomycin (PS) showed good results in the sperm quality and in the reproductive in vivo trials, but it showed a very poor effect inhibiting bacterial growth probably due to some kind of antibiotic resistance. According to our results, there is not a significant positive relationship between the higher bacterial inhibitory activity of LS and PS samples, and the sperm quality respect Control samples (without antibiotics). In the case of G, which exhibited the most effective as antibacterial, we observed a toxic effect on sperm quality that could be translated on productivity parameters. Our results suggest that the bacterial contamination control in frozen-thawed semen may be possible without the use of antibiotics, although the effects of longer periods of cooling storage and different temperatures of storage need to be further investigated for animal semen. At this point, a reflection about a drastic reduction in the use of antibiotic treatments in sperm cryopreservation is mandatory, since freezing conditions could keep sperm doses contamination within the levels recommended by regulatory health agencies.Entities:
Keywords: antibiotic resistance; antibiotics; artificial insemination; fertility; ovine semen; prolificacy; sex-ratio
Year: 2021 PMID: 34150884 PMCID: PMC8211462 DOI: 10.3389/fvets.2021.656937
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Figure 1Ram sperm motility data in the four experimental groups by time (just after thawing -T0- and after 2 h of incubation at 37°C -T2-): Control (C), without antibiotics; Penicillin-Streptomycin (PS); (500 UI)−625 μg/mL, respectively; Lincomycin-Spectinomycin (LS); 300–600 μg/mL respectively; and Gentamicin (G) 1,000 μg/mL. (A) Total motility (TM, %); (B) progressive motility (PM, %); (C) rapid progressive motile sperm (Rapid PM, %), (D) amplitude of the lateral head movement (ALH, μm), (E) velocity according to the straight path (VSL, μm/s), and (F) velocity according to the smoothed path (VAP, μm/s). Nine males were analyzed (1 ejaculate per male) including the same males in each experimental group. Graph dots represent individual male ejaculate. Significant differences (P < 0.05) are represented with an asterisk between the antibiotic treatment and the Control sample without antibiotics.
Figure 2Ram sperm multiparametric flow cytometry data in the four experimental groups by time (just after thawing -T0- and after 2 h of incubation at 37°C -T2-): Control (C), without antibiotics; Penicillin-Streptomycin (PS); (500 UI)−625 μg/mL, respectively; Lincomycin-Spectinomycin (LS); 300–600 μg/mL, respectively; and Gentamicin (G) 1,000 μg/mL. (A) Zombie low intensity cells and Caspase 3&7 negative cells (viable not apoptotic sperm, %); (B) Zombie low intensity cells and Caspase 3/7 positive cells (apoptosis, %); (C) Zombie low intensity cells and CellROX-positive cells (Sperm with high metabolic activity, %). Nine males were analyzed (1 ejaculate per male) including the same males in each experimental group. Graph dots represent individual male ejaculate. Significant differences (P < 0.05) are represented with an asterisk between the antibiotic treatment and the Control sample without antibiotics.
Figure 3Total viable aerobic bacterial (colony-forming units) in the four experimental groups: Control (C), without antibiotics; Penicillin-Streptomycin (PS); (500 UI)−625 μg/mL, respectively; Lincomycin-Spectinomycin (LS) 300–600 μg/mL, respectively; and Gentamicin (G) 1,000 μg/mL. Eight males were analyzed (1 ejaculate per male) including the same males in each experimental group. Significant differences (P < 0.05) are represented with an asterisk between the antibiotic treatment and the Control sample without antibiotics.
Figure 4Bacterial species isolated in each treatment after thawing: Control (C), without antibiotics; Penicillin-Streptomycin (PS), (500 UI)−625 μg/mL, respectively; Lincomycin-Spectinomycin (LS), 300–600 μg/mL, respectively; and Gentamicin (G) 1,000 μg/mL. Eight males were analyzed (1 ejaculate per male) including the same males in each experimental group.
Fertility results (lambed ewe/100 inseminated ewe) by treatment as follows: Control (without antibiotics), Penicillin-Streptomycin; with Penicillin (500 UI) and Streptomycin to a final concentration of 625 μg/mL; Lincomycin-Spectinomycin to a final concentration of 300 and 600 μg/mL, respectively; and Gentamicin to a final concentration of 1,000 μg/mL.
| Control | 221 | 117 | 52.9a |
| Penicillin-Streptomycin | 211 | 105 | 49.7a |
| Lincomycin-Spectinomycin | 206 | 104 | 50.5a |
| Gentamicin | 214 | 83 | 38.8b |
Ten males were used.
Different low case letters (a,b) indicate significant differences (P < 0.05) among treatments.
Multiple lambing frequency (%), prolificacy (lambs/lambed ewe), and fecundity results (lambs/inseminated ewes) by treatment as follows: Control (without antibiotics), Penicillin-Streptomycin; with Penicillin (500 UI) and Streptomycin to a final concentration of 625 μg/mL; Lincomycin-Spectinomycin to a final concentration of 300 and 600 μg/mL, respectively; and Gentamicin to a final concentration of 1,000 μg/mL.
| Control | 48.72ab | 1.52 ± 0.05ab | 0.81 ± 0.06a |
| Penicillin-Streptomycin | 55.24a | 1.67 ± 0.07a | 0.83 ± 0.07a |
| Lincomycin-Spectinomycin | 41.35b | 1.47 ± 0.06b | 0.74 ± 0.06ab |
| Gentamicin | 45.78ab | 1.53 ± 0.07ab | 0.59 ± 0.06b |
Ten males were used.
Different low case letters (a,b) indicate significant differences (P < 0.05) among treatments.
Figure 5The sex-ratio results for female (females/100 lambs) in the four experimental groups: Control (C), without antibiotics; Penicillin-Streptomycin (PS), (500 UI)−625 μg/mL, respectively; Lincomycin-Spectinomycin (LS), 300–600 μg/mL, respectively; and Gentamicin (G) 1,000 μg/mL. 371 ewes were inseminated with sperm doses from 10 males. *P ≤ 0.05, **P ≤ 0.01.